Eurofins Scient (OTCMKTS:ERFSF) Given Average Rating of “Moderate Buy” by Brokerages

Eurofins Scient (OTCMKTS:ERFSF) has earned an average recommendation of “Moderate Buy” from the six analysts that are presently covering the firm, MarketBeat Ratings reports. Four research analysts have rated the stock with a hold rating, one has assigned a buy rating and one has assigned a strong buy rating to the company.

ERFSF has been the topic of a number of research reports. Citigroup reissued a “neutral” rating on shares of Eurofins Scient in a report on Wednesday, October 22nd. BNP Paribas Exane upgraded shares of Eurofins Scient to an “outperform” rating in a research note on Monday, January 5th. Finally, Deutsche Bank Aktiengesellschaft restated a “hold” rating on shares of Eurofins Scient in a research note on Wednesday, October 29th.

Eurofins Scient Price Performance

ERFSF opened at $82.31 on Thursday. The firm has a 50 day moving average price of $75.53 and a 200-day moving average price of $74.50. Eurofins Scient has a twelve month low of $48.55 and a twelve month high of $86.20. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.26 and a quick ratio of 1.19.

Eurofins Scient Company Profile

Eurofins Scientific is a global provider of bioanalytical testing and laboratory services, offering a wide array of testing solutions to pharmaceutical, food, environmental, agriscience and consumer products industries. Its core services include pharmaceutical quality control, environmental testing for water and air quality, food safety analysis, agrochemical trials and clinical diagnostic support. The company operates specialized laboratories equipped with advanced analytical technologies such as chromatography, mass spectrometry and molecular biology to ensure compliance with regulatory standards and to support research and development efforts across multiple sectors.

Founded in 1987 by Gilles Martin and headquartered in Luxembourg, Eurofins has grown through a combination of organic expansion and strategic acquisitions.